The bovine mastitis market is experiencing significant growth, driven by rising disease prevalence, increased dairy production, and advancements in diagnostic and treatment methods. This article delves into the key aspects shaping the market landscape.

In 2019, the global bovine mastitis market was valued at USD 1.23 billion and is expected to grow to USD 1.84 billion by 2027, reflecting a compound annual growth rate (CAGR) of 5.2% over the forecast period. North America led the market in 2019, accounting for a dominant share of 32.52%.

Top Companies in the Market

• Zoetis (New Jersey, U.S.)
• Merck & Co., Inc. (MSD Animal Health) (New Jersey, U.S.)
• Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany)
• Bayer AG (Leverkusen, Germany)
• Elanco (Indiana, U.S.)
• Ceva (Libourne, France)
• West Way Health (Galway, Ireland)
• Others

Key Industry Development

In April 2021, Boehringer Ingelheim expanded its dairy mastitis portfolio by introducing the blue Ubroseal internal teat sealant. This product aims to prevent new intramammary infections during the dry period, enhancing udder health and milk quality.

Market Drivers & Restraints

Drivers:

• Increasing prevalence of bovine mastitis, leading to economic losses in the dairy industry.
• Growing demand for dairy products, necessitating improved animal health management.
• Advancements in diagnostic tools and treatment options, including non-antibiotic therapies.